Core Viewpoint - Annovis Bio, Inc. is hosting a live webcast to provide updates on its clinical trials for neurodegenerative diseases, specifically Alzheimer's disease and Parkinson's disease, while engaging with patients, caregivers, and families [1][2][3] Group 1: Webcast Details - The webcast will feature CEO Dr. Maria Maccecchini discussing the ongoing Phase 3 trial for Alzheimer's disease, plans for the Phase 3 trial for Parkinson's disease, and patient communication strategies [2] - A short presentation will highlight recent achievements, followed by a Q&A session where attendees can submit questions in advance [2] Group 2: Company Overview - Annovis Bio is headquartered in Malvern, Pennsylvania, focusing on innovative therapies for neurodegenerative diseases by targeting multiple neurotoxic proteins to restore brain function [4] - The company emphasizes its commitment to transparency and patient engagement, aiming to address questions from current and prospective patients [3] Group 3: Investor Engagement - Investors and shareholders are encouraged to sign up for press releases and industry updates through the company's email alerts [5] - The updated investor website offers comprehensive access to company news, financial reports, and other key information [5]
Annovis to Host Patients' Live Forum on February 27, 2025